VivoPower PLC (VIVO)
NASDAQ: VIVO · Real-Time Price · USD
1.890
-0.180 (-8.70%)
At close: Mar 16, 2026, 4:00 PM EDT
1.900
+0.010 (0.53%)
After-hours: Mar 16, 2026, 5:31 PM EDT
VivoPower Market Cap
VivoPower has a market cap or net worth of $31.73 million as of March 16, 2026. Its market cap has decreased by -96.45% in one year.
Market Cap
31.73M
Enterprise Value
59.01M
1-Year Change
-96.45%
Ranking
n/a
Category
Stock Price
$1.89
Market Cap Chart
Since December 1, 1998, VivoPower's market cap has decreased from $82.70M to $31.73M, a decrease of -61.63%. That is a compound annual growth rate of -3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2023 | 1.49B | 2.29% |
| Dec 30, 2022 | 1.46B | 64.54% |
| Dec 31, 2021 | 884.60M | 9.87% |
| Dec 31, 2020 | 805.10M | 92.79% |
| Dec 31, 2019 | 417.60M | -43.27% |
| Dec 31, 2018 | 736.10M | 24.55% |
| Dec 29, 2017 | 591.00M | -20.70% |
| Dec 30, 2016 | 745.30M | -13.21% |
| Dec 31, 2015 | 858.70M | 25.27% |
| Dec 31, 2014 | 685.50M | -37.77% |
| Dec 31, 2013 | 1.10B | 31.74% |
| Dec 31, 2012 | 836.10M | 7.62% |
| Dec 30, 2011 | 776.90M | -17.54% |
| Dec 31, 2010 | 942.10M | 7.75% |
| Dec 31, 2009 | 874.30M | -14.85% |
| Dec 31, 2008 | 1.03B | -14.40% |
| Dec 31, 2007 | 1.20B | 86.93% |
| Dec 29, 2006 | 641.70M | 22.25% |
| Dec 30, 2005 | 524.90M | 98.60% |
| Dec 31, 2004 | 264.30M | 70.74% |
| Dec 31, 2003 | 154.80M | 53.72% |
| Dec 31, 2002 | 100.70M | 14.56% |
| Dec 31, 2001 | 87.90M | 21.91% |
| Dec 29, 2000 | 72.10M | -31.79% |
| Dec 31, 1999 | 105.70M | 8.86% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 877.80B |
| AstraZeneca | 594.54B |
| Johnson & Johnson | 582.64B |
| AbbVie | 390.89B |
| CEL-SCI | 30.70M |
| Tiziana Life Sciences | 30.54M |
| BriaCell Therapeutics | 30.45M |
| Exicure | 30.28M |